Several animal studies have further shown that administration of GLP-1RAs, before or shortly after experimentally-induced stroke, increased angiogenesis, neurogenesis and cerebral blood flow (CBF), reduced neuroinflammation, oxidative stress, excitotoxicity, BBB leakage and apoptosis, and induced dose-dependent decreases in infarct volume [60,61,62]
Chronic inflammation in the body: Immune cells involved in inflammation in the body make their way into the brain and begin triggering inflammation there as well
In dog nutrition, supplementing with L-carnitine can help regulate body weight and support fat burning, especially in overweight dogs
Safety and metabolic effects of tesamorelin, a growth hormone-releasing factor analogue, in patients with type 2 diabetes: a randomized, placebo-controlled trial
Behavioral Interventions and Medication Durability Research suggests behavioral interventions enhance GLP-1 efficacy and weight-loss maintenance